10x genomics stock price.
As of Dec. 31, 10x had $219.7 million in cash and cash equivalents, $210.2 million in marketable securities, and $2.6 million in restricted cash. 10x Genomics expects full-year 2023 revenue to be in the range of $580 million to $600 million, representing 12 percent to 16 percent growth over 2022 revenue.
Investor Relations. We are a life science technology company building products to interrogate, understand and master biology. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. We have built deep expertise across diverse ...Some 10x Genomics, Inc. shareholders may be a little concerned to see that the Chief Commercial Officer, James Wilbur, recently sold a substantial US$619k worth of stock at a price of US$42.09 per share.Probably the most concerning element of the whole transaction is that the disposal amounted to 87% of their entire holding. View our …Summary of all time highs, changes and price drops for 10x Genomics; Historical stock prices; Current Share Price: US$43.36: 52 Week High: US$63.57: 52 Week LowStock split history for 10x Genomics since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
10x Genomics (TXG) delivered earnings and revenue surprises of -15.79% and 4.22%, respectively, for the quarter ended March 2023. ... The sustainability of the stock's immediate price movement ...10x Genomics Stock Forecast and Price Target. According to two esteemed experts, the average price target for 10x Genomics to reach this year is $60.00, with a potential upside of approximately 40.48%. This prediction is based on a high estimate of $70.00 and a low estimate of $30.00.View the latest 10x Genomics Inc. (TXG) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Investor Relations. We are a life science technology company building products to interrogate, understand and master biology. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. We have built deep expertise across diverse ...
Shares of 10x Genomics are in a yearlong rut. After the company went public in 2019, its shares soared to a peak in mid-2021. Since then, however, TXG stock has generally trended down.39.73 +0.01 (+0.03%) After hours: 03:53PM EST 1d 5d 1m 6m YTD 1y 5y Max Full screen Trade prices are not sourced from all markets Press Releases Find the latest 10x …10x Genomics : Provides high ... Sells DNA at rock bottom prices, a necessary ingredient for the synthetic biology revolution. ... 10x Genomics stock fell hard during the biotech crash of 2022 ...Don’t write all synthetic biology stocks off just because the meme stocks crashed and burned! Here are 3 DNA stocks to buy for the synthetic biology revolution. TXG. 10x Genomics. $52.64. CRL ...
If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.
On average, Wall Street analysts predict. that 10x Genomics's share price could reach $58.67 by Sep 29, 2024. The average 10x Genomics stock price prediction forecasts a potential upside of 65.35% from the current TXG share price of $35.48 .
10X Genomics Inc Stock Price History. 10X Genomics Inc’s price is currently up 17.4% so far this month. During the month of March, 10X Genomics Inc’s stock price has reached a high of $56.22 and a low of $43.25. Over the last year, 10X Genomics Inc has hit prices as high as $83.34 and as low as $23.81. Year to date, 10X Genomics Inc’s ...NanoString Technologies Inc. -7.89%. $26.34M. TXG | Complete 10x Genomics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Sep 18, 2023 · 10x Genomics appears to be significantly undervalued based on the GF Value calculation. At its current price of $47.68 per share, the stock's long-term return is likely to be much higher than its ... 10x Genomics (NASDAQ: TXG) $43.35 (1.3%) $0.54 Price as of November 22, 2023, 4:00 p.m. ET Financial Health Earnings Transcripts Key Data Points Current Price $43.35 …Stock analysis for 10X Genomics Inc (TXG:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
For 10x Genomics stock forecast for 2023, 2 predictions are offered for each month of 2023 with average 10x Genomics stock forecast of $38.85, a high forecast of $38.92, and a low forecast of $38.77. The average 10x Genomics stock forecast 2023 represents a 0.87% increase from the last price of $38.5099983215332. Don’t write all synthetic biology stocks off just because the meme stocks crashed and burned! Here are 3 DNA stocks to buy for the synthetic biology revolution. TXG. 10x Genomics. $52.64. CRL ...At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.What is the target price for 10x Genomics (TXG) stock? The latest price target for 10x Genomics ( NASDAQ: TXG) was reported by Barclays on Friday, September 29, 2023. The analyst firm set a price ... Operating expenses included non-cash stock-based compensation of $3.1 million for the fourth quarter of 2022 and $2.9 million for the fourth quarter of 2021. The year-over-year increase in operating expenses was driven primarily by scaling headcount and infrastructure to support our growth, including the G4 launch, product pipeline and R&D roadmap.
Nov 27, 2023 · 10x Genomics Stock Forecast and Price Target. According to two esteemed experts, the average price target for 10x Genomics to reach this year is $60.00, with a potential upside of approximately 40.48%. This prediction is based on a high estimate of $70.00 and a low estimate of $30.00.
8 analysts have issued 12 month target prices for 10x Genomics' stock. Their TXG share price targets range from $47.00 to $75.00. On average, they predict the company's stock price to reach $60.78 in the next twelve months. This suggests a possible upside of 42.3% from the stock's current price.At 10x Genomics, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.Nov 30, 2023 · UBS Lowers 10x Genomics Price Target to $44 From $62, Maintains Neutral Rating. Nov. 07. MT. OWKIN Integrates 10x Genomics, Inc. Spatial Omics and Single-Cell Technologies to the MOSAIC Study. Nov. 06. CI. Earnings Flash (TXG) 10X GENOMICS Reports Q3 Revenue $153.6M, vs. Street Est of $151.3M. Nov. 02. Nov 14, 2023 · 10X Genomics Inc Stock Price History. 10X Genomics Inc’s price is currently up 13.01% so far this month. During the month of November, 10X Genomics Inc’s stock price has reached a high of $40.08 and a low of $33.79. Over the last year, 10X Genomics Inc has hit prices as high as $63.57 and as low as $31.28. Year to date, 10X Genomics Inc’s ... 10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. ... Consensus Price Target is the stock price analysts ...Aug 4, 2023 · Related news 10x Genomics Clears Technical Benchmark, Hitting 80-Plus RS Rating. 9/12/2023 10x Genomics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from ... Based on short-term price targets offered by 12 analysts, the average price target for 10x Genomics comes to $56.00. The forecasts range from a low of $30.00 to a high of $70.00. The average price ...
1. Illumina Inc CFD. Illumina is considered to be one of the leading companies in the sub-sector of genetic sequencing. Illumina has a current market cap of $23.82 billion (as of September 2023), showing a strong position in the sector.
10x Genomics, Inc. Class A Common Stock (TXG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Dec 1, 2023 · 10x Genomics Inc Ordinary Shares - Class A TXG Morningstar Rating Unlock Stock XNAS Rating as of Dec 1, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials... Nov 20, 2023 · See the latest 10x Genomics Inc Ordinary Shares - Class A stock price (0A88:LTS), related news, valuation, dividends and more to help you make your investing decisions. According to 7 analyst offering 12-month price targets in the last 3 months, 10x Genomics has an average price target of $60.57 with a high of $68.00 and a low of $30.00. Below is a summary of how ...Nov 30, 2023 · Company Summary. 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in ... Nov 17, 2023 · 10X Genomics Inc Stock Price History. 10X Genomics Inc’s price is currently up 19.53% so far this month. During the month of November, 10X Genomics Inc’s stock price has reached a high of $42.25 and a low of $33.79. Over the last year, 10X Genomics Inc has hit prices as high as $63.57 and as low as $31.28. Year to date, 10X Genomics Inc’s ... A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. As at June 2023, 10x Genomics had cash of US$391m ...10x Genomics appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.Analyst Michael Ryskin of Bank of America Securities reiterated a Sell rating on 10x Genomics (TXG – Research Report), with a price target of $36.00. Michael Ryskin has given his Sell rating due ...10X GENOMICS INC. 10X GENOMICS INC 0A88 Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.
Baron Discovery Fund (the Fund) reached its 10-year anniversary on September 30, 2023. Since inception, on a cumulative basis, the fund was up 195.3% (Institutional Shares) compared to the Russell 2000 […] Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital information to help you with your stock trading and ...10X Genomics Inc’s Stock Price as of Market Close. As of March 31, 2023, 4:00 PM CST, 10X Genomics Inc’s stock price was $55.79. 10X Genomics Inc is up 7.19% from its previous closing price of $52.05. During the last market session, 10X Genomics Inc’s stock traded between $51.10 and $52.37. Currently, there are 114.77 …Shares of 10x Genomics are in a yearlong rut. After the company went public in 2019, its shares soared to a peak in mid-2021. Since then, however, TXG stock has generally trended down.Instagram:https://instagram. balance sheet for appleblk dividendhow much is a 1979 silver dollar coin worthstock td 10x Genomics (TXG) delivered earnings and revenue surprises of -15.79% and 4.22%, respectively, for the quarter ended March 2023. ... The sustainability of the stock's immediate price movement ... johnson and johnson dividend yieldone cent 2009 value Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.10x Genomics (NASDAQ:TXG) adds US$133m to market cap in the past 7 days, though investors from a year ago are still down 75%. (Simply Wall St.) Dec-08-22 04:05PM. 10x Genomics Commercially Launches Xenium Platform for In Situ Analysis. (PR Newswire) +7.27%. calculate pip Find the latest 10x Genomics, Inc. (TXG) stock quote, history, news and other vital information to help you with your stock trading and investing.Currently, 10X Genomics Inc does not have a price-earnings ratio. 10X Genomics Inc’s trailing 12-month revenue is $568.4 million with a -30.3% net profit margin. Year-over-year quarterly sales growth most recently was 28.1%. ... Overall, 10X Genomics Inc stock has a Value Score of 6, Estimate Revisions Score of 27 and Quality Score of 66.